Metraipolis › archive › dc_dcc122a69002

Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape — Europe PMC PMID:41756324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41756324
DOI
10.3389/fonc.2026.1771549
License (as archived)
solo-consultazione
Archived
2026-11-05T22:46:32.976Z
SHA-256 of the archived text
a85b53663b0b4e6b52d65cf11bb84ac8f5d537b65fa53a7b2e55325388f9e98a
Stable URL of this page
https://metraipolis.com/documento/dc_dcc122a69002

How to cite

Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape — Europe PMC PMID:41756324 — Europe PMC (en), https://europepmc.org/article/MED/41756324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dcc122a69002 (Metraipolis archive dc_dcc122a69002, sha256 a85b53663b0b4e6b52d65cf11bb84ac8f5d537b65fa53a7b2e55325388f9e98a)
BibTeX
@misc{dcdcc122a69002,
  title = {Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape — Europe PMC PMID:41756324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41756324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dcc122a69002; sha256 a85b53663b0b4e6b52d65cf11bb84ac8f5d537b65fa53a7b2e55325388f9e98a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756324. Agents can read the archived copy with the MCP tool read_document.